article thumbnail

Scientists discover a secret to regulating our body clock, offering new approach to end jet lag

Science Daily: Pharmacology News

Scientists have discovered the secret to regulating our internal clock.

article thumbnail

Stellar winds regulate growth of galaxies

Science Daily: Pharmacology News

Although this had already been observed in the local universe, an international research team has just revealed the existence of the phenomenon in galaxies which are more than 7 billion years old and actively forming stars, the category to which most galaxies belong.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AI Regulations for Financial Services: SEC

Perficient: Drug Development

Artificial intelligence (AI) is poised to affect every aspect of the world economy and play a significant role in the global financial system, leading financial regulators around the world to take various steps to address the impact of AI on their areas of responsibility.

article thumbnail

FDA Programs to Support Advanced Manufacturing: Where Innovation Meets Regulation

The Premier Consulting Blog

One of the key facets of the OCET program is providing internal training opportunities to FDA staff, to build their expertise with the novel technologies. Contact us today to find out how we can support your program.

article thumbnail

The Evolving Landscape of Quality Management Systems in Life Sciences

thought leadership

In the decades since the FDA first introduced Good Manufacturing Practice (GMP) regulations, the drug and device industry has undergone significant transformation. Alongside these innovations, global supply chains have expanded, requiring manufacturers to coordinate with international partners, each subject to unique regulatory standards.

Science 75
article thumbnail

FDA Inspections: Lesson 1 – Interviewing Employees

FDA Law Blog: Biosimilars

As part of the Food and Drug Administration Safety and Innovation Act (known as FDASIA) and later under the FDA Reauthorization Act of 2017 (known as FDARA), a drug or medical device can be deemed adulterated if a regulated company delays, denies, or limits an inspection, or refuses to permit an entry or inspection. FD&C Act 501(j).

FDA 105
article thumbnail

U.K. regulator lays out proposal for international device and diagnostics recognition

Agency IQ

BY COREY JASEPH, MS, RAC The British medical device regulator just issued its promised framework on international recognition.